Rtw Investments »

Aktis Oncology shares owned by Rtw Investments

Quarter-by-quarter ownership of Aktis Oncology shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Rtw Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $29M 1.6M 17.89

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Cg Oncology (CGON)
Celcuity (CELC)
Tango Therapeutics (TNGX)
Erasca (ERAS)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Cogent Biosciences (COGT)

View all positions for Rtw Investments

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
Wellington Management Company
BlackRock
Rtw Investments
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management

View all funds holding Aktis Oncology